A role for the proteasome regulator PA28alpha in antigen presentation
- PMID: 8610016
- DOI: 10.1038/381166a0
A role for the proteasome regulator PA28alpha in antigen presentation
Abstract
Cytotoxic T cells recognize viral proteins as peptide fragments which are produced in the cytosol and transported on major histocompatibility complex (MHC) class I proteins to the cell surface. Viral peptides that meet the stringent binding characteristics of class I proteins are generated by the 20S proteasome. The interferon (IFN)-gamma-inducible activator of the 20S proteasome, PA28, strongly influences the proteasomal cleavage pattern in vitro. This led us to investigate whether changes in cellular levels of PA28 affect the efficiency of viral antigen processing. A mouse fibroblast line expressing the murine cytomegalovirus pp89 protein was transfected with either the human or murine gene encoding the PA28alpha subunit, which is sufficient to activate the peptide-hydrolysing activity of the 20S proteasome in vitro. Here we report that enhanced expression of PA28alpha at a level similar to that obtained after IFN-gamma induction resulted in a marked enhancement of recognition by pp89-specific cytotoxic T cells; the presentation of influenza nucleoprotein was also significantly improved. These results demonstrate a fundamental in vivo function for PA28alpha in antigen processing.
Similar articles
-
Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.Eur J Immunol. 1994 Aug;24(8):1863-8. doi: 10.1002/eji.1830240822. Eur J Immunol. 1994. PMID: 8056044
-
The proteasome regulator PA28alpha/beta can enhance antigen presentation without affecting 20S proteasome subunit composition.Eur J Immunol. 2000 Dec;30(12):3672-9. doi: 10.1002/1521-4141(200012)30:12<3672::AID-IMMU3672>3.0.CO;2-B. Eur J Immunol. 2000. PMID: 11169410
-
Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.Cancer Res. 2002 May 15;62(10):2875-82. Cancer Res. 2002. PMID: 12019167
-
The proteasome activator 11 S REG (PA28) and class I antigen presentation.Biochem J. 2000 Jan 1;345 Pt 1(Pt 1):1-15. Biochem J. 2000. PMID: 10600633 Free PMC article. Review.
-
The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response.Biol Chem. 1999 Mar;380(3):293-7. doi: 10.1515/BC.1999.040. Biol Chem. 1999. PMID: 10223331 Review.
Cited by
-
Deciphering preferential interactions within supramolecular protein complexes: the proteasome case.Mol Syst Biol. 2015 Jan 5;11(1):771. doi: 10.15252/msb.20145497. Mol Syst Biol. 2015. PMID: 25561571 Free PMC article.
-
The ubiquitin-proteasome pathway: on protein death and cell life.EMBO J. 1998 Dec 15;17(24):7151-60. doi: 10.1093/emboj/17.24.7151. EMBO J. 1998. PMID: 9857172 Free PMC article. Review. No abstract available.
-
The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death.Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2727-30. doi: 10.1073/pnas.95.6.2727. Proc Natl Acad Sci U S A. 1998. PMID: 9501156 Free PMC article. No abstract available.
-
PA28αβ: the enigmatic magic ring of the proteasome?Biomolecules. 2014 Jun 19;4(2):566-84. doi: 10.3390/biom4020566. Biomolecules. 2014. PMID: 24970231 Free PMC article. Review.
-
Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens.PLoS One. 2017 Jul 18;12(7):e0181382. doi: 10.1371/journal.pone.0181382. eCollection 2017. PLoS One. 2017. PMID: 28719652 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
